Lower urinary tract symptoms in survivors of COVID-19: a prospective cohort study with hospitalized controls

Mostafaei H1, Vahabi B2, Abolhasanpour N3, Aletaha R3, Salehi-Pourmehr H3, Hajebrahimi S4, Shariat S1

Research Type

Clinical

Abstract Category

Female Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction

Abstract 602
Open Discussion ePosters
Scientific Open Discussion Session 105
Thursday 8th October 2026
13:50 - 13:55 (ePoster Station 4)
Exhibition Hall
Incontinence Mixed Urinary Incontinence Overactive Bladder
1. Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria, 2. School of Applied Sciences, University of the West of England, Bristol, UK., 3. Research Center for Evidence-Based Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., 4. Department of Urology, Imam Reza Hospital, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Presenter
Links

Abstract

Hypothesis / aims of study
To evaluate whether COVID-19 survivors have a higher prevalence and severity of LUTS and urinary incontinence compared to hospitalized non-COVID controls over an 8 month follow-up.
Study design, materials and methods
In this prospective cohort study, we included adults hospitalized between March 2022 and June 2023.We compared patients with laboratory-confirmed SARS-CoV-2 infection were compared with hospitalized controls without a history of COVID-19. LUTS were assessed using validated questionnaires at baseline, 3 months, and 8 months after discharge.
Results
A total of 441 patients were included comprising 232 COVID-19 survivors and 209 hospitalized controls. Compared to controls, female COVID-19 survivors had greater rates of nocturia and urinary frequency at 8-month follow-up. Stress urinary incontinence was also more frequent among female COVID-19 survivors at follow-up. No significant differences were observed between groups for urgency urinary incontinence, enuresis, or post-voiding incontinence. Among men, differences were limited and less consistent.
Interpretation of results
The findings suggest that prior SARS-CoV-2 infection may be associated with a modest but clinically relevant increase in selected storage lower urinary tract symptoms (LUTS), particularly among women. The higher rates of nocturia, urinary frequency, and stress urinary incontinence in female COVID-19 survivors at 8 months may reflect persistent post-infectious effects on bladder function, potentially mediated through inflammatory, neurogenic, or urothelial mechanisms. The absence of significant differences in urgency urinary incontinence and other incontinence subtypes indicates that the effect may be symptom-specific rather than a global deterioration of lower urinary tract function. The limited and inconsistent findings in men further support a possible sex-related susceptibility. Overall, these results highlight a potential long-term urological sequela of COVID-19 in selected populations, warranting increased clinical awareness and further mechanistic and longitudinal investigations to clarify causality and underlying pathways.
Concluding message
COVID-19 survivors, particularly women, demonstrated a higher prevalence of selected storage LUTS during follow-up compared with hospitalized non-COVID controls. This indicates a possible association between prior SARS-CoV-2 infection and persistent urinary symptoms in selected cases, highlighting the need for targeted evaluations and further longitudinal research.
Disclosures
Funding no funding Clinical Trial No Subjects Human Ethics Committee Ethics committee of Tabriz University of Medical Sciences Helsinki Yes Informed Consent Yes AI For simple textual assistance in writing the abstract manuscript
07/06/2026 04:01:43